Jun 24th, 2022 - Gaps in priorities and perceptions about managing disease exist between physicians and patients with ulcerative colitis (UC), according to survey findings recently published in Therapeutic Advances in Gastroenterology. The results – which come from the Ulcerative Colitis Narrative Survey from Japan – point to the ongoing need to foster a good relationship between physicians and patients, even a.

Jun 24th, 2022 - How much does the risk of new-onset type 2 diabetes (T2D) increase in patients who have had a mild SARS-CoV-2 (COVID-19) infection? Dr. Jain: We are now finding many associations between COVID-19 and T2D.

Jun 23rd, 2022 - CHARLOTTE, N. C.

Jun 23rd, 2022 - An open-label extension of Biogen’s phase 3 VALOR study shows statistically significant benefits for the company’s novel antisense oligonucleotide (ASO), tofersen, in patients with amyotrophic lateral sclerosis (ALS) caused by superoxide dismutase 1 (SOD1) gene mutations. The 1-year results, presented at the European Network for the Cure of Amyotrophic Lateral Sclerosis (ENCALS) 2022 meeting, s.

Jun 23rd, 2022 - DENVER – Monoclonal antibodies, antivirals, immunomodulators, and pulmonary arterial vasodilators top the list of drugs that were most frequently implicated as causes of headaches in a federal side effect database that anyone can contribute to, according to a new study presented at the annual meeting of the American Headache Society. “Surprising findings included the significant number of immun.

Jun 23rd, 2022 - Key clinical point: Stereotactic body radiotherapy (SBRT) plus transcatheter arterial chemoembolization (TACE) may be safe and more effective than either of the procedures alone (monotherapy) for treating inoperable hepatocellular carcinoma (HCC) with portal vein tumor thrombus (PVTT). Major finding: SBRT plus TACE vs.

Jun 23rd, 2022 - Key clinical point: Nonalcoholic fatty liver disease (NAFLD) is independently associated with an increased risk for hepatocellular carcinoma (HCC). Major finding: NAFLD significantly increased the risk for HCC (hazard ratio [HR] 1.

Jun 23rd, 2022 - Key clinical point: Patients with breast cancer (BC) treated with standard chemotherapy during pregnancy show comparable prognosis to young nonpregnant patients with BC, supporting chemotherapy initiation in pregnant women with BC as indicated. Major finding: Median follow-up was 66.

Jun 23rd, 2022 - Chemotherapy, now streaming at just $15. 99 a month! It’s a lazy Sunday and you flip on Netflix, looking for something new to watch.

Jun 23rd, 2022 - Key clinical point: In patients with high-risk operable breast cancer (BC) and without diabetes, adding metformin to standard BC treatment did not improve the invasive disease-free survival (iDFS) rate, regardless of estrogen receptor/progesterone receptor (ER/PgR) status. Major finding: The incidence rates of iDFS events were similar between the metformin and placebo groups in patients with ER.

Jun 23rd, 2022 - Key clinical point: The combination of camrelizumab, apatinib, and eribulin demonstrated a favorable efficacy and a manageable safety profile in patients with heavily pretreated advanced triple negative breast cancer (TNBC). Major finding: The objective response rate (ORR), disease control rate, and median progression-free survival in the overall cohort were 37.

Jun 23rd, 2022 - Key clinical point: In a real-world setting, patients initiating dupilumab reported longstanding moderate-to-severe atopic dermatitis (AD) with frequent type 2 comorbidities and poor quality of life (QoL). Major finding: Patients reported experiencing AD for a median duration of 17 years, with 93.

Jun 23rd, 2022 - Human papilloma virus (HPV) vaccination coverage of at least one dose significantly increased in U. S.

Jun 23rd, 2022 - Christopher V. DeSimone, MD, PhD: Hello, and welcome back to the Mayo Clinic–Medscape video series. I'm Dr Christopher DeSimone, cardiologist and director of cardiovascular marketing here at Mayo Clinic. Today we're going to be discussing leaks after left atrial appendage closure and how this can increase stroke risk. I'm joined by my colleague, Dr Mohamad Alkhouli, professor of interventional ...

Jun 23rd, 2022 - This transcript has been edited for clarity. In the 2022 Management of Hyperglycemia consensus statement from the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD), the focus has shifted. Regarding the management of hyperglycemia, we feel a more holistic approach is needed. What we mean by that is a four-part simultaneous attention on glycemic man...

Jun 23rd, 2022 - In reflecting on the racial disparities that exist in dermatology and on a broader healthcare level, Jonathan Silverberg, MD, PhD, MPH, considers dermatologic knowledge gaps in terms of accurately recognizing distinct manifestations of atopic dermatitis across diverse populations. Dr Silverberg refers to the typical manifestations of atopic dermatitis seen in Black patients, such as more lichen...

Jun 23rd, 2022 - This transcript has been edited for clarity. Vallerie McLaughlin, MD: Hello. I'm Dr Vallerie McLaughlin, the Kim A. Eagle Endowed Professor of Cardiovascular Medicine at the University of Michigan in Ann Arbor. I would like to welcome you to today's Medscape InDiscussion series on pulmonary arterial hypertension (PAH). This is episode 2: diagnosis of PAH. What are the challenges and why does it...

Jun 23rd, 2022 - This transcript has been edited for clarity. Vallerie McLaughlin, MD: Hello, and welcome to this podcast series. I'm Dr Vallerie McLaughlin, the Kim A. Eagle Endowed Professor of Cardiovascular Medicine and director of the Pulmonary Hypertension Program at the University of Michigan Medical School in Ann Arbor, Michigan. I'm joined today by my dear friend and colleague, Dr Raymond Benza from Oh...

Jun 23rd, 2022 - Editor's Note: The Case Challenge series includes difficult-to-diagnose conditions, some of which are not frequently encountered by most clinicians but are nonetheless important to accurately recognize. Test your diagnostic and treatment skills using the following patient scenario and corresponding questions. If you have a case you would like to suggest for a future Case Challenge, please conta...

Jun 23rd, 2022 - MADRID (Reuters) - Spain's national health ministry on Wednesday denied a report by regional counterparts that a case of locally acquired cholera had been detected for the first time in four decades, saying the case was in fact vibrio gastroenteritis. A female patient was hospitalised in a private health care facility in Madrid and was later discharged after receiving treatment, a spokesperson ...